바로가기 메뉴
본문 바로가기
주메뉴 바로가기
김희연

Hee Yeon Kim

Breast surgery division (Breast center)

Specialty

Breast disease, general surgery department

Treatment hours

Mon, Tue, Wed, Thur, Fri, Sat
Mon Tue Wed Thu Fri Sat
Education

Ulsan Science High School graduation (2009)

M.D. degree

College of Medicine, Inje University (2015)

Master's degree

Department of Medicine, Graduate School, Inje University

Thesis: Plasma and urinary endogenous metabolites as possible surrogate biomarkers for breast cancer screening: Preliminary study

Career

Ulsan Science High School graduation (2009)

M.D. degree

College of Medicine, Inje University (2015)

Master's degree

Department of Medicine, Graduate School, Inje University

Thesis: Plasma and urinary endogenous metabolites as possible surrogate biomarkers for breast cancer screening: Preliminary study

Main Activities


Research/Publication

1. Lee A, Kim HY, Kim TH, Ahn KJ, Cho H, Park SK, Choi Y. Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis. J Korean Med Sci. 2022 Feb;37(8):e64. (First-author)

2. Jin Hee Park, Hee Yeon Kim, Anbok Lee, Young Kyeong Seo, Il-Hwan Kim, Eun-tae Park, Mi Seon Kang, Sung Jae Park, SaeGwang Park, Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1, International Journal of Radiation Oncology*Biology*Physics, Volume 110, Issue 2,2021,Pages 510-520,ISSN 0360-3016, (First-author)

3. Kim HY, Kim TH, Yoon HK, Lee A. The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer. J Breast Cancer. 2019 Sep;22(3):425-438. (First-author)

4.Kim, H.Y., Choi, JH., Haque, M.M. et al. Combined treatment with anti-HER2/neu and anti-4-1BB monoclonal antibodies induces a synergistic antitumor effect but requires dose optimization to maintain immune memory for protection from lethal rechallenge. Cancer Immunol Immunother 71, 967?978 (2022). (First-author)

5.Nguyen Phuoc Long, Dayoung Heo, Hee-Yeon Kim, Tae Hyun Kim, Jae-Gook Shin, Anbok Lee, Dong-Hyun Kim,

Metabolomics-guided global pathway analysis reveals better insights into the metabolic alterations of breast cancer, Journal of Pharmaceutical and Biomedical Analysis, Volume 202,2021,114134,

ISSN 0731-7085, (Co-author)

6.Lee A, Jin H, Masudul Haque M, Kim HY, Jung H, Park JH, Kim I, Song JY, Yoon HK, Kim HK, Kim HK, et al: Synergism of a novel MCL-1 downregulator, acriflavine, with navitoclax (ABT?263) in triple?negative breast cancer, lung adenocarcinoma and glioblastoma multiforme. Int J Oncol 60: 2, 2022 (co-author)

7.Quan X, Lee J-, Park JH, Haque M., Kim HY, Kim I, et al. Induction of Triple-negative Breast Cancer Cells to Immunogenic Cell Death and Increase Cross-Presentation by Streptomyces sanyensis. Pharmacognosy Research. 2021;13(3):165-172. (co-author)